Cargando…
Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia
(1) Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke is limited because of several contraindications. In routine clinical practice, patients with a recent stroke are typically not treated with rt-PA in case of a recurrent ischemic...
Autores principales: | Gelhard, Sarah, Kestner, Roxane-Isabelle, Armbrust, Moritz, Steinmetz, Helmuth, Foerch, Christian, Bohmann, Ferdinand O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225099/ https://www.ncbi.nlm.nih.gov/pubmed/35743425 http://dx.doi.org/10.3390/jcm11123343 |
Ejemplares similares
-
Impact of Stress Hyperglycemia on Early Neurological Deterioration in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
por: Wang, Ling, et al.
Publicado: (2022) -
No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke
por: Bohmann, Ferdinand, et al.
Publicado: (2012) -
Blood Pressure Lowering Decreases Intracerebral Hemorrhage Volume and Improves Behavioral Outcomes in Experimental Animals
por: Bohmann, Ferdinand O., et al.
Publicado: (2020) -
Predictors of Early Neurological Deterioration Following Intravenous Thrombolysis: Difference between Risk Factors for Ischemic and Hemorrhagic Worsening
por: Nair, Srikumar B., et al.
Publicado: (2022) -
Long-term Prognosis of Patients Who Contraindicated for Intravenous Thrombolysis in Acute Ischemic Stroke
por: Lee, Bo-Yeon, et al.
Publicado: (2019)